Operating Income - Abbvie Inc (NYSE:ABBV) - Alpha Spread

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 196.48 USD 1.72% Market Closed
Market Cap: 348B USD
Have any thoughts about
Abbvie Inc?
Write Note

Abbvie Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Operating Income Peer Comparison

Comparables:
GILD
AMGN
ALNY
VRTX
REGN

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Operating Income
$16B
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Operating Income
$10.3B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Operating Income
$6.2B
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
-1%
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Operating Income
$102.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Income
$4.2B
CAGR 3-Years
23%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Income
$4.2B
CAGR 3-Years
-14%
CAGR 5-Years
14%
CAGR 10-Years
17%

See Also

What is Abbvie Inc's Operating Income?
Operating Income
16B USD

Based on the financial report for Jun 30, 2024, Abbvie Inc's Operating Income amounts to 16B USD.

What is Abbvie Inc's Operating Income growth rate?
Operating Income CAGR 10Y
10%

Over the last year, the Operating Income growth was -20%. The average annual Operating Income growth rates for Abbvie Inc have been -1% over the past three years , 5% over the past five years , and 10% over the past ten years .

Back to Top